Basic Information | Post buying leads | Suppliers |
Name |
Mineral oil, petroleum extracts, heavy naphthenic distillate solvent |
EINECS | N/A |
CAS No. | 64742-11-6 | Density | N/A |
PSA | N/A | LogP | N/A |
Solubility | N/A | Melting Point |
N/A |
Formula | N/A | Boiling Point | N/A |
Molecular Weight | N/A | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Confirmed carcinogen. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits acrid smoke and irritating fumes. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Heavynaphthenic distillate solvent extract (petroleum) |
Mineral oil, petroleum extracts, heavy naphthenic distillate solvent (CAS NO.64742-11-6) is also called Extracts (petroleum), heavy naphthenic distillate solvent ; Extracts, petroleum, heavy naphthenic distillate solvent . The EINECS of Mineral oil, petroleum extracts, heavy naphthenic distillate solvent (CAS NO.64742-11-6) is 265-111-0. The Product Categories of Mineral oil, petroleum extracts, heavy naphthenic distillate solvent (CAS NO.64742-11-6) is UVCBs-organic.
IARC Cancer Review: Group 1 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 252.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 33 ,1984,p. 87.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Reported in EPA TSCA Inventory.
Confirmed carcinogen. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits acrid smoke and irritating fumes.
Hazard Codes: T
Risk Statements: 45
R45:May cause cancer.
Safety Statements: 53-45
S53:Avoid exposure - obtain special instructions before use.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)